Low Frequency of Intermittent HIV-1 Semen Excretion in Patients Treated with Darunavir-Ritonavir at 600/100 Milligrams Twice a Day plus Two Nucleoside Reverse Transcriptase Inhibitors or Monotherapy

• Published in: Antimicrobial Agents and Chemotherapy Vol. 54; no. 11; pp. 4910 - 4913
• Main Authors: LAMBERT-NICLOT, Sidonie, PEYTAVIN, Gilles, KATLAMA, Christine, CALVEZ, Vincent, MARCELIN, Anne-Geneviève, DUVIVIER, Claudine, POIROT, Catherine, ALGARTE-GENIN, Michèle, PAKIANATHER, Sophie, MEYNARD, Jean-Luc, VALANTIN, Marc-Antoine, MOLINA, Jean-Michel, FLANDRE, Philippe
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.11.2010; American Society for Microbiology (ASM)
• Subjects: Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral Agents; Biological and medical sciences; Darunavir; Drug Administration Schedule; HIV Infections - blood; HIV Infections - drug therapy; HIV Infections - metabolism; HIV-1 - drug effects; HIV-1 - pathogenicity; Human immunodeficiency virus 1; Human viral diseases; Humans; Immunodeficiencies; Immunodeficiencies. Immunoglobulinopathies; Immunopathology; Infectious diseases; Male; Medical sciences; Pharmacology. Drug treatments; Plasma - chemistry; Reverse Transcriptase Inhibitors; Reverse Transcriptase Inhibitors - blood; Reverse Transcriptase Inhibitors - metabolism; Reverse Transcriptase Inhibitors - therapeutic use; Ritonavir; Ritonavir - blood; Ritonavir - metabolism; Ritonavir - therapeutic use; RNA, Viral - genetics; Semen - chemistry; Sulfonamides; Sulfonamides - blood; Sulfonamides - metabolism; Sulfonamides - therapeutic use; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Biological fluid; Antiretroviral agent; Darunavir; HIV-1 virus; Ritonavir; Non peptide compound; Low frequency; Intermittent; Reverse transcriptase inhibitor; Antiviral; Nucleoside; Human; Immunopathology; Drug combination; Excretion; Enzyme; Semen; Enzyme inhibitor; Retroviridae; Patient; AIDS; Immune deficiency; Lentivirus; Infection; Virus; Peptidases; Treatment; Viral disease; Hydrolases; Human immunodeficiency virus; Pharmacokinetics; Protease inhibitor
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.00725-10

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC